top of page
Website Badges (3).png
Polaris Genomics
Bringing molecular diagnostics to mental health
INVESTMENt

May, 2023

Sector

Health-Tech

FUND

Fund 2

location

Rockville, Maryland

co-investors

Sanford Health
Acacia Capital Group
Wing Two
Illumina
Viking Global Investors

Sonia Szamocki 32co ceo

Charles Cathlin

CEO

Alertive.png
Quintuple aim

Polaris Genomics is decoding the biological fingerprints of mental health to advance the discovery and development of tools and diagnostics for a range of conditions, including PTSD, depression/anxiety, ADHD, TBI, and substance use disorder. Drawing upon decades of experience in biomedical technology, public health, & molecular biology, Polaris Genomics was founded to address the current mental health crisis.

WM360_logo-18.png
bottom of page